{"id":10649,"date":"2021-08-19T04:24:09","date_gmt":"2021-08-19T04:24:09","guid":{"rendered":"https:\/\/i3tk.org\/demo2\/?p=10649"},"modified":"2021-08-19T04:24:12","modified_gmt":"2021-08-19T04:24:12","slug":"working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2","status":"publish","type":"post","link":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/","title":{"rendered":"Working on nasal vaccine as booster dose, says Bharat Biotech CMD"},"content":{"rendered":"\n<p>NEW DELHI:&nbsp;<a href=\"https:\/\/health.economictimes.indiatimes.com\/tag\/bharat+biotech\">Bharat Biotech<\/a>&nbsp;is working on a combination of&nbsp;<a href=\"https:\/\/health.economictimes.indiatimes.com\/tag\/covaxin\">Covaxin<\/a>&nbsp;followed by&nbsp;<a href=\"https:\/\/health.economictimes.indiatimes.com\/tag\/nasal\">nasal<\/a>&nbsp;vaccine which if administered can act as a booster dose and protect a person from getting infected, according to its chairman and managing director Dr&nbsp;<a href=\"https:\/\/health.economictimes.indiatimes.com\/tag\/krishna+ella\">Krishna Ella<\/a>.<\/p>\n\n\n\n<p>The company expects significant data on the combination in the next two months which can then drive the future course of action based on regulatory approvals and policy decision regarding booster shots.<\/p>\n\n\n\n<p>\u201cWe are working on a combination of Covaxin followed by nasal, so that Covaxin primes the system of innate immunity and then the boost by the nasal which produces three immune responses \u2014 the IGG, the IGA and then mucosal immunity. All three immunities are powerful and can protect a person from getting infected,\u201d Ella said at the Times Now India@75: The Freedom Summit.<\/p>\n\n\n\n<p>Even as Covaxin is found to be significantly effective against the dominant Delta virus, the government will take the final call on whether there is a need for a third dose of Covaxin to enhance the immune response for a longer time, Ella said underlining that data will be submitted to the government. \u201cI think we have done a booster dose also. We are waiting for the results, but if you recommend a booster dose, there will be a shortage of vaccine. So, it\u2019s a complicated situation. We are therefore adopting an innovative method,\u201d he said.<\/p>\n\n\n\n<p>According to Ella, if the nasal vaccine works out well, production capacity is also likely to double. At present, Bharat Biotech is supplying around 2 \u2014 2.5 crore doses of Covaxin per month, which is projected to increase to around 5.8 crore doses over the next few months.<\/p>\n\n\n\n<p>Amid concerns about limited supply of Covaxin and a slow ramp up of production as compared to other anti-Covid jabs, Ella highlighted how manufacturing an inactivated vaccine and expanding production capacity is reasonably difficult as compared to other platforms.<\/p>\n\n\n\n<p>\u201cThe mRNA vaccine can be produced with one of the easiest technologies in the world. You can produce in a week, and you can produce 20 million doses with mRNA. Coming to the adenovirus, which is a vector-based vaccine, I can manufacture in less than seven days. Whereas the same inactivated vaccine that we produce to be used in children, that can take 120 days to produce. The other two platforms, it is easy to scale up to 2,000 litres, 5,000 litres, whereas when it comes to inactivated vaccines, nobody has scaled up more than 1,000 litres in the world and we are the first company trying to scale it to 5,000 litres in our Bengaluru facility. People have not understood how complicated this technology is, and this is one of the oldest technologies and the best,\u201d he said.<\/p>\n\n\n\n<p>Ella also clarified that WHO approval for Covaxin got delayed as the company had to do efficacy trials separately and during the second wave, which involved cases of Delta variant.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bharat Biotech is working on a combination of Covaxin followed by nasal vaccine which if administered can act as a booster dose and protect a person from getting infected, according to its chairman and managing director Dr Krishna Ella.<\/p>\n","protected":false},"author":1,"featured_media":10650,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[87],"tags":[],"class_list":["post-10649","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-resources"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v18.8 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Working on nasal vaccine as booster dose, says Bharat Biotech CMD - International Institute of Innovation and Technology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Working on nasal vaccine as booster dose, says Bharat Biotech CMD\" \/>\n<meta property=\"og:description\" content=\"Bharat Biotech is working on a combination of Covaxin followed by nasal vaccine which if administered can act as a booster dose and protect a person from getting infected, according to its chairman and managing director Dr Krishna Ella.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/\" \/>\n<meta property=\"og:site_name\" content=\"International Institute of Innovation and Technology\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/International-Institute-of-Innovation-and-Technology-101979535699954\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-19T04:24:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-08-19T04:24:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i3tk.org\/demo2\/wp-content\/uploads\/2021\/08\/cdc-AY9uFreZrcw-unsplash.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"428\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@i3tkolkata\" \/>\n<meta name=\"twitter:site\" content=\"@i3tkolkata\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#\\\/schema\\\/person\\\/2ed104da3b2d63ba12c40da792d0bf2e\"},\"headline\":\"Working on nasal vaccine as booster dose, says Bharat Biotech CMD\",\"datePublished\":\"2021-08-19T04:24:09+00:00\",\"dateModified\":\"2021-08-19T04:24:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\\\/\"},\"wordCount\":497,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/cdc-AY9uFreZrcw-unsplash.jpg\",\"articleSection\":[\"Resources\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\\\/\",\"url\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\\\/\",\"name\":\"Working on nasal vaccine as booster dose, says Bharat Biotech CMD - International Institute of Innovation and Technology\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/cdc-AY9uFreZrcw-unsplash.jpg\",\"datePublished\":\"2021-08-19T04:24:09+00:00\",\"dateModified\":\"2021-08-19T04:24:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/cdc-AY9uFreZrcw-unsplash.jpg\",\"contentUrl\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/cdc-AY9uFreZrcw-unsplash.jpg\",\"width\":640,\"height\":428},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Working on nasal vaccine as booster dose, says Bharat Biotech CMD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#website\",\"url\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/\",\"name\":\"International Institute of Innovation and Technology\",\"description\":\"Advancing New Frontiers in Research &amp; Education\",\"publisher\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#organization\",\"name\":\"International Institute of Innovation and Technology (I3TK)\",\"url\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/i3tk-logo-v1.jpg\",\"contentUrl\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/i3tk-logo-v1.jpg\",\"width\":200,\"height\":200,\"caption\":\"International Institute of Innovation and Technology (I3TK)\"},\"image\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/International-Institute-of-Innovation-and-Technology-101979535699954\",\"https:\\\/\\\/x.com\\\/i3tkolkata\",\"https:\\\/\\\/www.instagram.com\\\/i3tkolkata\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCOXcio6zwQO3YSQkwoZKNrQ\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#\\\/schema\\\/person\\\/2ed104da3b2d63ba12c40da792d0bf2e\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/52146bcbad3565e9d842646770b21e26751c22d5978bb87fce2c8fd80777bbda?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/52146bcbad3565e9d842646770b21e26751c22d5978bb87fce2c8fd80777bbda?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/52146bcbad3565e9d842646770b21e26751c22d5978bb87fce2c8fd80777bbda?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/i3tk.org\\\/demo2\"],\"url\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Working on nasal vaccine as booster dose, says Bharat Biotech CMD - International Institute of Innovation and Technology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/","og_locale":"en_US","og_type":"article","og_title":"Working on nasal vaccine as booster dose, says Bharat Biotech CMD","og_description":"Bharat Biotech is working on a combination of Covaxin followed by nasal vaccine which if administered can act as a booster dose and protect a person from getting infected, according to its chairman and managing director Dr Krishna Ella.","og_url":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/","og_site_name":"International Institute of Innovation and Technology","article_publisher":"https:\/\/www.facebook.com\/International-Institute-of-Innovation-and-Technology-101979535699954","article_published_time":"2021-08-19T04:24:09+00:00","article_modified_time":"2021-08-19T04:24:12+00:00","og_image":[{"width":640,"height":428,"url":"https:\/\/i3tk.org\/demo2\/wp-content\/uploads\/2021\/08\/cdc-AY9uFreZrcw-unsplash.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@i3tkolkata","twitter_site":"@i3tkolkata","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/#article","isPartOf":{"@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/"},"author":{"name":"admin","@id":"https:\/\/i3tk.org\/demo2\/#\/schema\/person\/2ed104da3b2d63ba12c40da792d0bf2e"},"headline":"Working on nasal vaccine as booster dose, says Bharat Biotech CMD","datePublished":"2021-08-19T04:24:09+00:00","dateModified":"2021-08-19T04:24:12+00:00","mainEntityOfPage":{"@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/"},"wordCount":497,"commentCount":0,"publisher":{"@id":"https:\/\/i3tk.org\/demo2\/#organization"},"image":{"@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/#primaryimage"},"thumbnailUrl":"https:\/\/i3tk.org\/demo2\/wp-content\/uploads\/2021\/08\/cdc-AY9uFreZrcw-unsplash.jpg","articleSection":["Resources"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/","url":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/","name":"Working on nasal vaccine as booster dose, says Bharat Biotech CMD - International Institute of Innovation and Technology","isPartOf":{"@id":"https:\/\/i3tk.org\/demo2\/#website"},"primaryImageOfPage":{"@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/#primaryimage"},"image":{"@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/#primaryimage"},"thumbnailUrl":"https:\/\/i3tk.org\/demo2\/wp-content\/uploads\/2021\/08\/cdc-AY9uFreZrcw-unsplash.jpg","datePublished":"2021-08-19T04:24:09+00:00","dateModified":"2021-08-19T04:24:12+00:00","breadcrumb":{"@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/#primaryimage","url":"https:\/\/i3tk.org\/demo2\/wp-content\/uploads\/2021\/08\/cdc-AY9uFreZrcw-unsplash.jpg","contentUrl":"https:\/\/i3tk.org\/demo2\/wp-content\/uploads\/2021\/08\/cdc-AY9uFreZrcw-unsplash.jpg","width":640,"height":428},{"@type":"BreadcrumbList","@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/working-on-nasal-vaccine-as-booster-dose-says-bharat-biotech-cmd-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/i3tk.org\/demo2\/"},{"@type":"ListItem","position":2,"name":"Working on nasal vaccine as booster dose, says Bharat Biotech CMD"}]},{"@type":"WebSite","@id":"https:\/\/i3tk.org\/demo2\/#website","url":"https:\/\/i3tk.org\/demo2\/","name":"International Institute of Innovation and Technology","description":"Advancing New Frontiers in Research &amp; Education","publisher":{"@id":"https:\/\/i3tk.org\/demo2\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/i3tk.org\/demo2\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/i3tk.org\/demo2\/#organization","name":"International Institute of Innovation and Technology (I3TK)","url":"https:\/\/i3tk.org\/demo2\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/i3tk.org\/demo2\/#\/schema\/logo\/image\/","url":"https:\/\/i3tk.org\/demo2\/wp-content\/uploads\/2022\/01\/i3tk-logo-v1.jpg","contentUrl":"https:\/\/i3tk.org\/demo2\/wp-content\/uploads\/2022\/01\/i3tk-logo-v1.jpg","width":200,"height":200,"caption":"International Institute of Innovation and Technology (I3TK)"},"image":{"@id":"https:\/\/i3tk.org\/demo2\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/International-Institute-of-Innovation-and-Technology-101979535699954","https:\/\/x.com\/i3tkolkata","https:\/\/www.instagram.com\/i3tkolkata\/","https:\/\/www.youtube.com\/channel\/UCOXcio6zwQO3YSQkwoZKNrQ"]},{"@type":"Person","@id":"https:\/\/i3tk.org\/demo2\/#\/schema\/person\/2ed104da3b2d63ba12c40da792d0bf2e","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/52146bcbad3565e9d842646770b21e26751c22d5978bb87fce2c8fd80777bbda?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/52146bcbad3565e9d842646770b21e26751c22d5978bb87fce2c8fd80777bbda?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/52146bcbad3565e9d842646770b21e26751c22d5978bb87fce2c8fd80777bbda?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/i3tk.org\/demo2"],"url":"https:\/\/i3tk.org\/demo2\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/posts\/10649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/comments?post=10649"}],"version-history":[{"count":0,"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/posts\/10649\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/media\/10650"}],"wp:attachment":[{"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/media?parent=10649"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/categories?post=10649"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/tags?post=10649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}